Pulmatrix
PULM
$1.95
Share price
2.63%
Change (1 day)
-27.24%
Change (1 year)
Categories
Operating Margin for Pulmatrix (PULM)
Operating Margin as of June 2024 (TTM): -310.26%
According to Pulmatrix's latest financial reports and stock price the company's current Operating Margin is -310.26%. At the end of 2021 the company had an Operating Margin of -320.95%.
Operating Margin history for Pulmatrix from 2016 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -320.95% | 311.16% |
| 2020 | -78.06% | -70.02% |
| 2019 | -260.38% | -98.04% |
| 2018 | -13,318.30% | 156.22% |
| 2017 | -5,197.91% | 45.06% |
| 2016 | -3,583.35% | 70.68% |
| 2015 | -2,099.42% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Pieris Pharmaceuticals PIRS | -128.47% | -58.59% | 🇺🇸 USA |
 OPKO Health
OPK | -36.36% | -88.28% | 🇺🇸 USA |
 Blueprint Medicines
BPMC | -244.45% | -21.21% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.